The effects of pregnancy on autoimmune diseases

Journal of Leukocyte Biology

Volumn 63, Issue 3, 1998, Pages 281-287

  Buyon, Jill P ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Lupus; Rheumatic diseases; Scleroderma

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CONGENITAL HEART BLOCK; FEMALE; FETUS DEATH; HUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

SCLERODERMA;

EID: 0031929762     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.3.281     Document Type: Review

References (68)

1. Wegmann, T. G., Lin, H., Guilbert, L., Mosmann, T. R. (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14, 353-356.
2. Petri, M. (1997) Rheumatic Disease Clinics of North America, Vol. 23, No. 1. Pregnancy and Rheumatic Disease. Philadelphia: Saunders, 1-218.
3. Branch, D. W. (1992) Physiologic adaptations of pregnancy. Am. J. Repro. Immunol. 28, 120-122.
4. Gregory, C. D., Shah, L. P., Lee, H., Scott, I. V., Golding, P. R. (1985) Cytotoxic reactivity of human natural killer (NK) cells during normal pregnancy. A longitudinal study. J. Clin. Lab. Immunol. 18, 175-181.
5. Scridama, V., Pacini, F., Yang, S. L., Moawad, A., Reilly, M., DeGroot, L. J. (1982) Decreased levels of helper T cells. A possible cause of immunodeficiency in pregnancy. N. Engl. J. Med. 307, 353-356.
6. Sites, D. P., Siiteri, P. K. (1983) Steroids as immunosuppressants in pregnancy. Immunol. Rev. 75, 117-138.
7. Maurolis, G. B., Buckley, R. H., Younger, J. B. (1971) Serum immunoglobulin concentrations during normal pregnancy. Am. J. Obstet. Gynecol. 109, 971-976.
8. Patton, P. E., Coulam, C. B., Bergstralth, E. (1987) The prevalence of autoantibodies in pregnant and non-pregnant women. Am. J. Obstet. Gynecol. 157, 1345-1350.
9. Dorner, T., Chaoui, R., Feist, E., Goldner, B., Yamamoto, K., Hiepe, F. (1995) Significantly increased maternal and fetal IgG autoantibody levels to 52kD Ro (SS-A) and La (SS-B) in complete congenital heart block. J. Autoimmun. 8, 675-684.
10. Amino, N., Kuro, R., Tanizawa, O., Tanaka, F., Hayashi, C., Kotani, K., Kawashima, M., Miyai, K., Kumahara, Y. (1978) Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin. Exp. Immunol. 31, 30-37.
11. Hunt, J. S., Andrews, G. U., Wood, G. W. (1987) Normal trophoblast resist induction of class I HLA. J. Immunol. 138, 2481-2487.
12. Payne, R. (1957) Leukocyte agglutinins in human sera. Arch. Intern. Med. 99, 587-591.
13. Van Der Ven, K., Ober, C. (1994) HLA-G polymorphisms in African-Americans. J. Immunol. 153, 5628-5633.
14. Pazmany, L., Mandelboim, O., Vales-Gomez, M., Davis, D. M., Reyburn, H. T., Strominger, J. L. (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274, 792-795.
15. Rouas-Freiss, N., Marchal-Bras Goncalves, R., Menier, C., Dausset, J., Carosella, E. D. (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 94, 11520-11525.
16. Hench, P.S. (1938) The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis, and intermittent hydrathrosis. Proc. Staff Meet. Mayo Clinic 13, 161-167.
17. Oka, M., Vaino, U. (1966) Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheumatol. Scand. 12, 47-52.
18. Ostensen, M., Aure, B., Husby, G. (1983) Effects of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand. J. Rheumatol. 12, 69-72.
19. Pope, R. M., Yoshinoya, S., Rutstein, J., Persellin, R. H. (1983) Effects of pregnancy on the prognosis and serology of rheumatoid arthritis. Am. J. Med. 74, 973-979.
20. Van Den Brink, H. R., Van Everdingen, A., Van Wijk, M. J. G., Jacobs, J. W. G., Bjilsma, J. W. J. (1992) Adjuvant estrogen therapy has no effect on disease activity in postmenopausal women with active rheumatoid arthritis. Arthr. Rheumatol. 35, S202.
21. Wolfson, W. Q., Robinson, W. D., Duff, I. F. (1951) The probability that increased secretion of oxysteroids does not fully explain improvement in certain systemic diseases during pregnancy. J. Mich. State Med. Soc. 50, 1019-1022.
22. Nelson, J. L., Hughes, K. A., Smith, A. G., Nisperos, B. B., Branchaud, A. M., Hansen, J. A. (1993) Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N. Engl. J. Med. 329, 466-171.
23. Englehard, V. (1994) Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12, 181-207.
24. Spector, T., Roman, E., Silman, A. (1990) The pill, parity, and rheumatoid arthritis. Arthr. Rheumatol. 33, 782-789.
25. Hazes, J. M. W., Dijkmans, B. A. C., Vandenbroucke, J. P., DeVries, R. R. P., Cats, A. (1990) Pregnancy and the risk of developing rheumatoid arthritis. Arthr. Rheumatol. 33, 1770-1775.
26. McGill, P. E., Brougham, P. A. (1990) Sex, hormones and rheumatoid arthritis: The nun's story. Br. J. Rheumatol. 29, 159.
27. Nelson, J. L., Woigt, L. F., Koepsell, T. D., Dugowson, C. E., Daling, J. R. (1990) Pregnancy outcome in women with rheumatoid arthritis before disease onset. Arthr. Rheumatol. 33, S29.
28. Lockshin, M. D., Reinitz, E., Druzin, M. L., Murrman, M., Estes, D. (1984) Lupus pregnancy. Case control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am. J. Med. 77, 893-898.
29. Petri, M., Howard, D., Repke, J. (1991) Frequency of lupus flares in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthr. Rheumatol. 34, 1538-1545.
30. Urowitz, M. B., Gladman, D. D., Farewell, V. T., Stewart, J., McDonald, J. (1993) Lupus and pregnancy studies. Arthr. Rheumatol. 36, 1392-1397.
31. Lockshin, M. D. (1993) Does lupus flare during pregnancy? (Editorial) Lupus 2, 1-2.
32. Buyon, J. P., Tamerius, J., Ordorica, S., Abramson, S. B. (1992) Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthr. Rheumatol. 35, 55-61.
33. Mintz, J. G., Niz, J., Gutierrez, C., Garcia-Alonso, A., Karchmer, S. (1986) Prospective study of pregnancy in systemic lupus erythematosus: results of a multidisciplinary approach. J. Rheumatol. 13, 732-739.
34. Meehan, R. T., Dorsey, J. K. (1987) Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J. Rheumatol. 14, 252-258.
35. Lockshin, M. D. (1989) Pregnancy does not cause systemic lupus erythematosus to worsen. Arthr. Rheumatol. 32, 665-670.
36. Nossent, H. C., Swaak, T. J. (1990) Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J. Rheumatol. 17, 771-776.
37. Tincani, A., Faden, D., Tarantini, M., Lojacono, A., Tanzi, P., Gastaldi, A., Di Mario, C., Spatola, L., Cattaneo, R., Balestrieri, G. (1992) Systemic lupus erythematosus and pregnancy: a prospective study. Clin. Exp. Rheumatol. 10, 439-446.
38. Buyon, J. P., Seligman, S., Clancy, R., Belmont, H. M., Young, B., Abramson, S. (1994) Increased serum nitrite levels in lupus pregnancies. Arthr. Rheumatol. 37, S324 (Abstract).
39. Imbasciati, E., Surian, M., Bottino, S., Cosei, P., Colussi, G., Ambroso, C., Massa, E., Minetti, L., Pardi, G. (1984) Lupus nephropathy and pregnancy. Nephron. 36, 46-51.
40. Hayslett, J. P., Lynn, R. I. (1980) Effect of pregnancy in patients with lupus nephropathy. Kidney Int. 18, 207-220.
41. Mayes, M. D., Giannini, E. H., Pachman, L. M., Buyon, J. P., Fleckman, P. (1997) Connective tissue disease registries. Arthr. Rheumatol. 40, 1556-1559.
42. Black, C. M. (1990) Systemic sclerosis and pregnancy. In Bailliere's Clinical Rheumatology (A. L. Parke, ed.), London: Bailliere Tindall, 105-121.
43. Steen, V. D, Conte, C., Day, N., Ramsey-Goldman, R., Medsger, T. A. (1989) Pregnancy in women with systemic sclerosis. Arthr. Rheumatol. 32, 151-157.
44. Simpson, J., Elias, S. (1993) Isolating fetal cells from maternal blood. J. Am. Med. Assoc. 270, 2357-2361.
45. Bianchi, D. (1994) Clinical trials and experience: Boston. Ann. NY Acad. Sci. 731, 147-153.
46. Nelson, J. L. (1996) Maternal-fetal immunology and autoimmune disease. Is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthr. Rheumatol. 39, 191-194.
47. Artlett, C. M., Smith, J. B., Jiminez, S. A. (1997) Identification of fetal cells in the active lesions of skin biopsies of women with systemic sclerosis. Arthr. Rheumatol. 40 (Suppl.), S218.
48. Lockshin, M. D., Druzin, M. L., Qamar, T. (1989) Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodies. Am. J. Obstet. Gynecol. 160, 439-443.
49. Lynch, A., Marlar, R., Murphy, J., Davila, G., Santos, M., Rutledge, J., Emlen, W. (1994) Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann. Intern. Med. 120, 470-476.
50. McNeil, H. P., Simpson, R. J., Chesterman, C. N., Krilis, S. A. (1990) Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87, 4120-4124.
51. Galli, M., Comfurius, P., Maassen, C., Hemker, H. C., De Baets, M. H., Van Breda-Vriesman, P. J., Barbui, T., Zwaal, R. F., Bevers, E. M. (1990) Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 335, 1544-1547.
52. Roubey, R. A. S., Pratt, C., Buyon, J. P., Winfield, J. B. (1992) Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I. J. Clin. Invest. 90, 1100-1104.
53. Lee, N. S., Brewer, H. B., Osborne, J. C. J. (1983) Beta2-glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H. J. Biol. Chem. 258, 4765-4770.
54. Schousboe, I. (1985) Beta2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66, 1086-1091.
55. Nimpf, J., Bevers, E. M., Bomans, P. H., Till, I. U., Wurm, H., Kostner, G. M., Zwaal, R. F. (1986) Prothrombinase activity of human platelets is inhibited by beta2-glycoprotein-I. Biochim. Biophys. Acta 884, 142-149.
56. Nimpf, J., Wurm, H., Kostner, G. M. (1987) Beta 2-glycoprotein I (apo-H) inhibits the release reaction of human platelet during ADP-induced aggregation. Atherosclerosis 63, 109-114.
57. Branch, D. W. (1994) Thoughts on the mechanism of pregnancy loss associated with the anti-phospholipid syndrome. Lupus 3, 275-280.
58. Cowchock, F. S., Reece, E. A., Balaban, D., Branch, D. W., Plouffle, L. (1992) Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am. J. Obstet. Gynecol. 166, 1318-1323.
59. Branch, D. W., Silver, R. M., Blackwell, J. L., Reading, J. C., Scott, J. R. (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol. 80, 614-620.
60. Buyon, J. P. (1992) Neonatal lupus syndromes. In Systemic Lupus Erythematosus (R. Lahita, ed.), London: Churchill Livingstone, 419-435.
61. Lee, L. A. (1993) Neonatal lupus crythematosus. J. Invest. Dermatol. 100, 9S-13S.
62. Buyon, J. P., Winchester, R. J., Slade, S. G., Arnett, F., Copel, J., Friedman, D., Lockshin, M. D. (1993) Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: Comparison of ELISA and immunoblot to measure anti-SSA/Ro and anti-SSB/La antibodies. Arthr. Rheumatol. 36, 1263-1273.
63. Waltuck, J., Buyon, J. P. (1994) Autoantibody associated complete heart block: Outcome in mothers and children. Ann. Intern. Med. 120, 544-551.
64. Garcia, S., Nascimento, J. H. M., Bonfa, E., Levy, R., Oliveira, S. F., Tavares, A. V., Campos DeCarvalho, A. C. (1994) Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J. Clin. Invest. 93, 718-724.
65. Boutjdir, M., Chen, L., Zhang, Z., Tseng, C., Di Donato, F., Rashbaum, W., Morris, A., El-Sherif, N., Buyon, J. P. (1997) Arrhythmogenicity of IgG and anti-52kD SSA/Ro affinity purified antibodies from mothers of children with congenital heart block. Circ. Res. 80, 354-362.
66. Miranda, E., Tseng, C., Chan, E. K. L., DiDonato, F., Boutjdir, M., Buyon, J. (1997) Induction of 52kD SSA/Ro antibodies and development of congenital heart block in a murine model. Arthr. Rheumatol. 40 (Suppl.), S123.
67. Rider, L., Buyon, J., Rutledge, J., Sherry, D. (1993) Postnatal treatment of neonatal lupus: Case report and review of the literature. J. Rheumatol. 20, 1208-1211.
68. Copel, J., Buyon, J., Kleinman, C. (1995) Successful in utero therapy of fetal heart block. Am. J. Obstet. Gynecol. 173, 1384-1390.